ELISA Diagnostic Test Market Size and Forecasts (2020 – 2030)

ELISA Diagnostic Test Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Send Enquiry
Item ID: TIPRE00030120 Category: Tags: , ,

$3,185$5,985

Description

The ELISA Diagnostic Test Market is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Key driving factors behind the market development are the rising infectious diseases among animals and the increasing incidence of human infections are the key driving factors behind the market development.

An enzyme-linked immunosorbent assay (ELISA) is a test that detects and measures antibodies in a patient’s blood. This test can be used to determine if the patient has antibodies related to certain infectious conditions. An ELISA test is used to diagnose HIV causing AIDS, Lyme disease, pernicious anemia, rotavirus, and among others. ELISA kits are a valuable research tool that offer quick, convenient, and precise detection and quantitation of specific targets in samples and cultures. Commercially available ELISA kits come with pre-coated plates, capture/detection antibodies, standards, buffers, and other necessary reagents. Each kit undergoes rigorous validation and stability testing to ensure accuracy, precision, sensitivity, specificity, and reproducibility.

Innovative Product Launches Creates Opportunities in ELISA Diagnostic Test Market.

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.

Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. “Human Factor IX Kit” is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests.

Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans.

In December 2022, Pictor Limited announced a new product launch of the “PictArray SARS-CoV-2 Antibody Test,” which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

Market Trend

Advancements in ELISA-Based Procedures

The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The “AMP’D ELISA Signal Amplification system” is manufactured by Enzo Life Sciences, Inc. The AMP’D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.

Cell Signaling Technology, Inc.’s “PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit,” designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarians for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020–2030.

Application-Based Insights

In terms of Application, the ELISA Diagnosis Test Market is categorized into autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR of 8.43% in the market during the 2022-2030. ELISA is a powerful technique in immunology for detecting antibodies and antigens and performing allergy testing and autoimmune disease diagnosis. The growing incidence of autoimmune diseases, and viral diseases (HIV, STI, hepatitis B, and others) across the world owing to the aged population and changes in demographics and lifestyle is driving the growth of the global ELISA diagnostic testing market. As per the statistics given by National Stem Cell Foundation in 2023, autoimmune diseases affect more than 80 different types of diseases and nearly 4% of the world’s population. The most common autoimmune diseases include type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn’s disease, psoriasis, and scleroderma. In the United States, autoimmune diseases are the third most common cause of chronic illness. Although rare, collectively, these diseases affect between 5% and 8% of the US population. For instance, according to an article published by PubMed Central in May 2022, conventional serological detection of Autoimmune bullous disease (AIBD) specific antibodies involves an initial screening using tissue substrates, followed by an antigen-specific assay such as ELISA.

Moreover, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market growth.

Based on test type, is segregated as sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022-2030.

The ELISA diagnostic test market, by end user, is categorized as hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospital & diagnostic centers segment held the largest share of the market during 2020-2030.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

According to our new research study on “ELISA Diagnostic Test Market Size and Forecast to 2030 – Global and Regional Analysis – by Adoption, Test Type, Application, and End User. The market is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Key driving factors behind the market development are the rising infectious diseases among animals and increasing incidence of human infections are the key driving factors behind the market development. However, incidents of product recalls are hampering the market growth.

Global ELISA Diagnostic Test market is segmented by region into North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America. The North America ELISA diagnostic test market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising infectious diseases among humans, acting as a standalone factor positively influencing the growth of the market. Additionally, technological advancements in ELISA diagnostic kits further enhances the overall market growth during 2022-2030.

Increasing Incidence of Human Infections to Drive the ELISA Diagnostic Test Market

According to the CDC report published in 2022, every year, 4 in 10 adults in the US have two or more diseases, with 6 in 10 adults having a chronic disease. Among the chronic diseases, over 1.7 million cancer diagnoses are conducted, and nearly 600,000 cancer deaths are recorded every year in the US. Additionally, more than 34 million people in the US (10.5%) have diabetes, with 88 million adults (more than 1 in 3) having prediabetes, resulting in an increase in the risk of suffering from type 2 diabetes. The healthcare expenditure on death and disability due to chronic diseases accounts for US$ 4.1 trillion annually in the US alone.

In humans, ELISA test is used as a biomarker to detect cancer, infectious diseases, autoimmunity, endocrinology diagnosis, immunology & cytokines, cell adhesion molecules (CAMs), and others. ELISA testing helps detect cancer at the early stage of diagnostic processes, offering a better chance for patient survival and getting appropriate treatment initially. Therefore, demand for ELISA testing is high across the world owing resulting in market growth during the forecast period.

?

By adoption, the ELISA diagnostic test market is segmented into human and veterinary. The ELISA diagnostic test market, by adoption, is bifurcated into human and veterinary. The human segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR of 7.88% during the forecast period. The veterinary segment was valued at US$ 446.67 million in 2022 and is expected to reach US$ 732.88 million by 2030. The growth rate of this segment is projected to be 6.39% during the forecast period. The adoption of ELISA tests in veterinary medicine is gaining importance owing to the growing prevalence of infectious diseases in domestic and wild animals. World Organization for Animal Health (WOAH) recommends ELISA tests for monitoring rabies-specific antibody titers, foot and mouth diseases, avian influenza disease, and many other viral infections in cattle, domestic, and poultry animals. For instance, in an article published in January 2023 by PubMed, the in-house ELISA (BukTi-Vet) developed to support post-vaccination monitoring in dogs was evaluated for its diagnostic performance compared to commercial ELISA kits.

Based on test type, market is segregated as sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR of 8.58% during the forecast period.

Based on application, market is categorized as autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.

The ELISA diagnostic test market, by end user, is categorized as hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospital & diagnostic centers segment held the largest share of the market in 2022

Major players in the ELISA diagnostic test market include B Braun SE; DePuy Synthes Inc.; Medtronic Plc; Siemens Healthineers AG; Stryker Corp.; ZimmerBiomet Holdings Inc.; Brainlab AG; CASCINATION; HEMOSTASIS, LLC; Corin Group; and GE HealthCare Technologies Inc. These leading players adopt strategies such as the launch of new products, expansion and diversification of their market presence, and expansion of new customer base for tapping prevailing business opportunities.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Dental Bone Graft Substitute and Barrier Membrane Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
5. North America Dental Bone Graft Substitute and Barrier Membrane Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Burden of Periodontal Diseases and Oral Cancer
5.1.2 Strategic Developments by Market Players
5.2 Market Restraints
5.2.1 High Cost of Products & Procedures and Delays in Dental Check-ups
5.3 Market Opportunities
5.3.1 Technological Developments in Dentistry
5.4 Future Trends
5.4.1 Digitization of Dentistry with CAD/CAM Technology
5.5 Impact Analysis:
6. Dental Bone Graft Substitute and Barrier Membrane Market – North America Market Analysis
6.1 North America Dental Bone Graft Substitute and Barrier Membrane Market Revenue (US$ Mn), 2022 – 2030
7. North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 North America Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Dental Bone Graft Substitute
7.3.1 Overview
7.3.2 Dental Bone Graft Substitute: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Allograft
7.3.3.1 Overview
7.3.3.2 Allograft: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Xenograft
7.3.4.1 Overview
7.3.4.2 Xenograft: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Synthetic Bone Graft
7.3.5.1 Overview
7.3.5.2 Synthetic Bone Graft: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Autografts
7.3.6.1 Overview
7.3.6.2 Autografts: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.3.7 Alloplasts
7.3.7.1 Overview
7.3.7.2 Alloplasts: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.3.8 Demineralized Bone Matrix (DBM)- Allograft
7.3.8.1 Overview
7.3.8.2 Demineralized Bone Matrix (DBM)- Allograft: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.3.9 Others
7.3.9.1 Overview
7.3.9.2 Others: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Dental Barrier Membrane
7.4.1 Overview
7.4.2 Dental Barrier Membrane: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 Resorbable Membrane
7.4.3.1 Overview
7.4.3.2 Resorbable Membrane: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Non-Resorbable Membrane
7.4.4.1 Overview
7.4.4.2 Non-Resorbable Membrane: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 – by Procedures
8.1 Overview
8.2 North America Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by Procedures 2022 & 2030 (%)
8.3 Guided Bone Regeneration Procedures (GBR)
8.3.1 Overview
8.3.2 Guided Bone Regeneration Procedures (GBR): North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Guided Tissue Regeneration Procedures (GTR)
8.4.1 Overview
8.4.2 Guided Tissue Regeneration Procedures (GTR): North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Sinus-lift Procedures and Ridge-split Procedures
8.5.1 Overview
8.5.2 Sinus-lift Procedures and Ridge-split Procedures: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Alveolar Ridge Preservation (ARP)
8.6.1 Overview
8.6.2 Alveolar Ridge Preservation (ARP): North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Block-graft Procedures
8.7.1 Overview
8.7.2 Block-graft Procedures: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Periodontal Regeneration Procedures
8.8.1 Overview
8.8.2 Periodontal Regeneration Procedures: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Socket Preservation
8.9.1 Overview
8.9.2 Socket Preservation: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Dental Clinics
9.4.1 Overview
9.4.2 Dental Clinics: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Dental Bone Graft Substitute and Barrier Membrane Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Dental Bone Graft Substitute and Barrier Membrane Market – Country Analysis
10.1 North America Dental Bone Graft Substitute and Barrier Membrane Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.1.1 North America Dental Bone Graft Substitute and Barrier Membrane Market, by Country
10.1.1.2 US
10.1.1.2.1 Overview
10.1.1.2.2 US Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 US Dental Bone Graft Substitute and Barrier Membrane Market, by Product
10.1.1.2.3.1 US Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
10.1.1.2.3.2 US Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
10.1.1.2.4 US Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
10.1.1.2.5 US Dental Bone Graft Substitute and Barrier Membrane Market, by End User
10.1.1.3 Canada
10.1.1.3.1 Overview
10.1.1.3.2 Canada Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Canada Dental Bone Graft Substitute and Barrier Membrane Market, by Product
10.1.1.3.3.1 Canada Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
10.1.1.3.3.2 Canada Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
10.1.1.3.4 Canada Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
10.1.1.3.5 Canada Dental Bone Graft Substitute and Barrier Membrane Market, by End User
10.1.1.4 Mexico
10.1.1.4.1 Overview
10.1.1.4.2 Mexico Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Mexico Dental Bone Graft Substitute and Barrier Membrane Market, by Product
10.1.1.4.3.1 Mexico Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
10.1.1.4.3.2 Mexico Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
10.1.1.4.4 Mexico Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
10.1.1.4.5 Mexico Dental Bone Graft Substitute and Barrier Membrane Market, by End User
11. North America Dental Bone Graft Substitute and Barrier Membrane Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in North America Dental Bone Graft Substitute and Barrier Membrane Market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. North America Dental Bone Graft Substitute and Barrier Membrane Market, Key Company Profiles
12.1 Geistlich Pharma AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Dentsply Sirona Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 ZimVie Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Regenity Biosciences Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Neoss UK & Ireland Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Institut Straumann AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Resorba Medical GmbH
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. ELISA Diagnostic Test Market Segmentation
Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
Table 3. North America US ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America US ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 7. Following is a list of zoonotic disease outbreaks spread between animals and people.
Table 8. US ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 9. US ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 10. US ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. US ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Mexico ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. Mexico ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 20. Europe ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 21. Europe ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 22. Europe ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 23. Europe ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 24. Germany ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 25. Germany ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 26. Germany ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 27. Germany ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 28. France ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 29. France ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 30. France ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. France ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 32. UK ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 33. UK ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 34. UK ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 35. UK ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 37. Italy ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 38. Italy ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 39. Italy ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 41. Spain ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 42. Spain ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 43. Spain ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 44. Rest of Europe ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 45. Rest of Europe ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 46. Rest of Europe ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 47. Rest of Europe ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 48. Asia Pacific ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 49. Asia Pacific ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 50. Asia Pacific ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 51. Asia Pacific ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 52. China ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 53. China ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 54. China ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 55. China ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 56. Japan ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 57. Japan ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 58. Japan ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 59. Japan ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 60. India ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 61. India ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 62. India ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 63. India ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 64. Australia ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 65. Australia ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 66. Australia ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 67. Australia ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 68. South Korea ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 69. South Korea ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 70. South Korea ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 71. South Korea ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 72. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 73. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 74. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 75. Rest of Asia Pacific ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 76. Middle East & Africa ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 77. Middle East & Africa ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 78. Middle East & Africa ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 79. Middle East & Africa ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 80. South Africa ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 81. South Africa ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 82. South Africa ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 83. South Africa ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 84. Saudi Arabia ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 85. Saudi Arabia ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 86. Saudi Arabia ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 87. Saudi Arabia ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 88. UAE ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 89. UAE ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 90. UAE ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 91. UAE ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 93. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 94. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 95. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 96. South & Central America ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 97. South & Central America ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 98. South & Central America ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 99. South & Central America ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 100. Brazil ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 101. Brazil ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 102. Brazil ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 103. Brazil ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 104. Argentina ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 105. Argentina ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 106. Argentina ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 107. Argentina ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of South & Central America ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of South & Central America ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 110. Rest of South & Central America ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 111. Rest of South & Central America ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 112. Recent Organic Growth Strategies in ELISA diagnostics Test Market
Table 113. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
Table 114. Glossary of Terms, ELISA Diagnostic Tests Market

LIST OF FIGURES

Figure 1. ELISA Diagnostic Test Market Segmentation, By Geography
Figure 2. PEST Analysis
Figure 3. ELISA Diagnostic Test Market: Key Industry Dynamics
Figure 4. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
Figure 5. ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 – 2030
Figure 6. Global ELISA Diagnostic Tests Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
Figure 8. Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 11. Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
Figure 16. Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America: ELISA Diagnostic Tests Market, by Key Country – Revenue (2022) (US$ Million)
Figure 27. North America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. North America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 29. US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Europe: ELISA Diagnostic Tests Market, by Key Country – Revenue (2022) (US$ Million)
Figure 33. Europe ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Europe: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 35. Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. Asia Pacific: ELISA Diagnostic Tests Market, by Key Country – Revenue (2022) (US$ Million)
Figure 42. Asia Pacific ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Asia Pacific: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 44. China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 47. Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 48. South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 49. Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. Middle East & Africa: ELISA Diagnostic Tests Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. Middle East & Africa ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. Middle East & Africa: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 53. South Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 54. Saudi Arabia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 55. UAE: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 56. Rest of Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 57. South & Central America: ELISA Diagnostic Tests Market, By Key Country – Revenue (2022) (US$ Million)
Figure 58. South & Central America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 59. South & Central America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 60. Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 61. Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 62. Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 63. Growth Strategies in ELISA diagnostics test Market

The List of Companies – ELISA Diagnostic Test Market
– Bio-Rad Laboratories Inc.
– Idexx Laboratories Inc.
– F. Hoffmann-La Roche Ltd.
– Thermo Fisher Scientific Inc.
– Abbott Laboratories
– Danaher Corp.
– Innovative Diagnostics SAS
– Pictor Ltd.
– DiaSorin SpA
– Elabscience Biotechnology Inc.
– Bio-Techne Corp.

Reviews

There are no reviews yet.

Be the first to review “ELISA Diagnostic Test Market Size and Forecasts (2020 – 2030)”